ERIBULINA ADVANZ PHARMA 0,44 MG/ML SOLUCIÓN INYECTABLE EFG

Advanz Pharma Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 2dd0ae6d51d9f1dd
Drug Cima Aemps Name: ERIBULINA ADVANZ PHARMA 0,44 MG/ML SOLUCIÓN INYECTABLE EFG
Register Number: 89176
Holder Company Name: Advanz Pharma Limited
Marketing Company Name: Advanz Pharma Spain S.L.U.
Holder Company Detail Path: /organization/advanz-pharma-international-limited
Authorization Date: 2023-12-01
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 0,44 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Advanz Pharma Limited
Company Detail Path: /organization/advanz-pharma-international-limited

ERIBULINA MESILATO

0,5 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 1, 2023

Approval ID

2dd0ae6d51d9f1dd

Type

Standard